From advanced surgical options to next-generation medications and cell-based therapies, researchers are closer than ever to ...

TOKYO, Feb 19 (Reuters) - Japan's health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma's iPS cell-derived treatment for Parkinson's disease, paving the way for the ...

Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to ...

Researchers say early deep brain stimulation and emerging therapies could reshape expectations for patients diagnosed in the U.S.

With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

PHILADELPHIA, PA - February 11, 2026 - PRESSADVANTAGE - Researchers at Thomas Jefferson University have found that ...

A Japanese health ministry panel on Thursday endorsed Sumitomo Pharma's iPS Cell-derived treatment for Parkinson's disease, the Mainichi Shimbun newspaper said.